Clorox (CLX) Misses Q3 EPS by 1c, Updates Guidance

Clorox (NYSE: CLX) reported Q3 EPS of $1.44, $0.01 worse than the analyst estimate of $1.45. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Clorox sees FY2019 EPS of $6.25-$6.35, versus the consensus of $6.31.

• 2% to 3% sales growth

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• SanDisk upgraded at JPMorgan after investor day; shares climb